3-Substituted-4-hydroxycoumarin as a new scaffold with potent CDK inhibition and promising anticancer effect: Synthesis, molecular modeling and QSAR studies
3-Substituted 4-hydroxycoumarin derivatives were synthesized.
•
All the synthesized target compounds selectively inhibited CDK1B.
•
3a, 6b and 8c showed in vitro and in vivo anticancer effects against MCF-7.
•
The Docking study confirmed a unique binding mode in CDK1B active site.
•
QSAR study revealed high predictive power (R2 = 0.81).
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.